Polyclinique de l'Ormeau

Futó vizsgálatok

• Toboroz

  Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

  NCT06606730· 3. fázis· Forrás

• Toboroz

  Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse

  NCT06625970· 3. fázis· Forrás

• Fut, nem toboroz

  Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizumab) and immunotherapy ( Pembrolizumab)

  NCT04262687· 2. fázis· Forrás

• Toboroz

  AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

  NCT05002556· Forrás

• Toboroz

  PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

  NCT04790253· Forrás

• Toboroz

  Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

  NCT04747054· 3. fázis· Forrás

• Toboroz

  Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

  NCT04325425· 2. fázis· Forrás

• Toboroz

  A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

  NCT04299646· 2. fázis· Forrás

• Toboroz

  PD-(L)1 iNhibitors with concurrent IRadiation at VAried tumour sites in advanced Non-small cell lung cAncer

  2024-512173-27-00· 3. fázis· Forrás

• Fut, nem toboroz

  PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

  NCT03774732· 3. fázis· Forrás

• Lezárult

  IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

  NCT02967289· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák2 toboroz
• Fej-nyaki daganatok1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hólyagrák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Prosztatarák1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Immediate Effects of STENDO on the Walking Abilities of Patients with COPD (STENDO-COPD)

  NCT05618509· Forrás

• Lezárult

  FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

  NCT03584711· 2. fázis· Forrás